Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Cancer Therapies02:49

Cancer Therapies

10.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

701
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
701
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

755
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
755
Oral Drug Delivery Systems: Introduction01:23

Oral Drug Delivery Systems: Introduction

108
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
108
Routes of Drug Administration: Parenteral01:25

Routes of Drug Administration: Parenteral

3.5K
The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Role of Distal Medial Cuneiform Angle in Hallux Valgus: A Systematic Review.

Cureus·2026
Same author

[Haab's striae secondary to congenital glaucoma: Role of anterior segment OCT].

Journal francais d'ophtalmologie·2025
Same author

Clinical review of laryngomalacia in a tertiary hospital.

The Medical journal of Malaysia·2025
Same author

Perinatal palliative care in an infant with exencephaly: Supporting life beyond 3 years of age.

Journal of neonatal-perinatal medicine·2025
Same author

[National protocol for diagnosis and treatment of Coats disease: Summary for attending and primary care physicians].

Journal francais d'ophtalmologie·2025
Same author

Real-life perception of pathology reports in urology.

Actas urologicas espanolas·2025
Same journal

News in oncology.

Indian journal of cancer·2026
Same journal

Unveiling the rare, interesting series of malignant mesenchymal tumors of the kidney in a regional cancer care institute in South India.

Indian journal of cancer·2026
Same journal

Why our unison matters: Head and neck cancer care providers.

Indian journal of cancer·2026
Same journal

District cancer control program: A white paper to optimize cancer care in rural India by developing a uniform, modular, and multi-tier system.

Indian journal of cancer·2026
Same journal

PI-RADS v2 score may be as a predictor of bone metastasis in prostate cancer.

Indian journal of cancer·2026
Same journal

Evaluation of sexual life quality and vaginal dose-volume relationship in female rectal cancer patients treated with pelvic radiotherapy.

Indian journal of cancer·2026
See all related articles

Related Experiment Video

Updated: Mar 9, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

31.4K

Innovation in chemotherapy administration process.

A Aziz1

  • 1Department of Oncology, Aga Khan University Hospital, Karachi, Pakistan.

Indian Journal of Cancer
|January 11, 2017
PubMed
Summary
This summary is machine-generated.

This study streamlined chemotherapy administration to reduce patient hospital stays and costs. Improvements in lab processing and physician order entry significantly decreased delays and financial burden for cancer patients.

More Related Videos

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
04:48

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

7.8K
Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.6K

Related Experiment Videos

Last Updated: Mar 9, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

31.4K
Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
04:48

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

7.8K
Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.6K

Area of Science:

  • Oncology
  • Healthcare Administration
  • Patient Services

Background:

  • Patient-reported increased cost burden due to prolonged hospital stays for chemotherapy administration (3-4 days).
  • Need to decrease hospital stay duration and financial burden for patients undergoing chemotherapy.
  • Objective to improve services for expedited chemotherapy administration.

Purpose of the Study:

  • To identify and address delays in the chemotherapy administration process.
  • To reduce hospital stay duration for patients receiving chemotherapy.
  • To decrease the financial burden associated with chemotherapy treatment.

Main Methods:

  • Review of 100 patient files from February 12, 2013, to May 15, 2013.
  • Analysis of service timings for inpatient chemotherapy administration.
  • Comparison of nine process timings against established benchmarks using a 'delays chemotherapy sheet'.

Main Results:

  • Process timings were generally close to benchmarks, with exceptions noted.
  • Delays identified in laboratory turnaround time for blood samples.
  • Significant delays in physician chemotherapy order entry for patients admitted after 4 p.m.
  • Delays also observed in the actual administration of chemotherapy.

Conclusions:

  • Identification of key factors contributing to chemotherapy administration delays.
  • Implementation of process improvements and innovations.
  • Successful reduction in hospital stay duration and associated costs for chemotherapy administration.